[{"address1": "2051 Ringwood Avenue", "city": "San Jose", "state": "CA", "zip": "95131", "country": "United States", "phone": "408 457 3700", "website": "https://www.ranitherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including large molecules, such as peptides, proteins, and antibodies. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The company was incorporated in 2012 and is headquartered in San Jose, California.", "fullTimeEmployees": 140, "companyOfficers": [{"maxAge": 1, "name": "Mr. Talat  Imran", "age": 41, "title": "CEO & Director", "yearBorn": 1982, "fiscalYear": 2022, "totalPay": 827000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Svai S. Sanford", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 661600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mir  Hashim", "age": 63, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 661600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Groen", "age": 52, "title": "General Counsel", "yearBorn": 1971, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bella  Vazquez", "title": "Vice President of Human Resources", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kate  McKinley M.B.A.", "title": "Chief Business Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Arvinder  Dhalla", "title": "Vice President of Clinical Development", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.4, "open": 5.4, "dayLow": 5.28, "dayHigh": 5.7951, "regularMarketPreviousClose": 5.4, "regularMarketOpen": 5.4, "regularMarketDayLow": 5.28, "regularMarketDayHigh": 5.7951, "beta": 0.916, "forwardPE": -8.636363, "volume": 176633, "regularMarketVolume": 176633, "averageVolume": 89043, "averageVolume10days": 136550, "averageDailyVolume10Day": 136550, "bid": 5.61, "ask": 5.77, "bidSize": 100, "askSize": 100, "marketCap": 293563680, "fiftyTwoWeekLow": 1.82, "fiftyTwoWeekHigh": 5.7951, "fiftyDayAverage": 3.5456, "twoHundredDayAverage": 3.236075, "currency": "USD", "enterpriseValue": 134757584, "floatShares": 13441244, "sharesOutstanding": 26040800, "sharesShort": 1920035, "sharesShortPriorMonth": 1714414, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.073699996, "heldPercentInsiders": 0.48416, "heldPercentInstitutions": 0.1337, "shortRatio": 22.33, "shortPercentOfFloat": 0.14140001, "impliedSharesOutstanding": 51502400, "bookValue": 0.494, "priceToBook": 11.538462, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -33970000, "trailingEps": -1.33, "forwardEps": -0.66, "pegRatio": 0.58, "enterpriseToEbitda": -2.064, "52WeekChange": -0.019963682, "SandP52WeekChange": 0.23416412, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "RANI", "underlyingSymbol": "RANI", "shortName": "Rani Therapeutics Holdings, Inc", "longName": "Rani Therapeutics Holdings, Inc.", "firstTradeDateEpochUtc": 1627651800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "5ed5bf18-2fc9-357f-8d44-03f1c0fe19bf", "messageBoardId": "finmb_242425883", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.7, "targetHighPrice": 12.0, "targetLowPrice": 4.0, "targetMeanPrice": 8.86, "targetMedianPrice": 9.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 48539000, "totalCashPerShare": 1.864, "ebitda": -65277000, "totalDebt": 30099000, "quickRatio": 6.101, "currentRatio": 6.365, "debtToEquity": 118.3, "returnOnAssets": -0.4979, "returnOnEquity": -1.3652099, "freeCashflow": -26958000, "operatingCashflow": -51236000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-15"}]